Targeting of MCL-1 in breast cancer associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
T. L. Bonneaud, L. Nocquet, A. Basseville, H. Weber, M. Campone, P. P. Juin, F. Souaze
This study shows that targeting MCL-1 in breast cancer-associated fibroblasts reduces their myofibroblastic traits and pro-invasive properties.
bioRxiv · Sep 24, 2021Cancer Biology